Picture of genOway SA logo

ALGEN — genOway SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: genOway H1 Net Result Turns To Profit Of EUR 0.2 Mln

Sept 19 (Reuters) - GENOWAY SA  ALGEN.PA :
    * H1 26% GROWTH IN ACTIVITY, INCLUDING 57% FOR CATALOGUE
MODELS
    * OUTLOOK 2022: GENERATE OVER EUR 17 MILLION IN REVENUE
    * H1 REVENUE EUR 7.8 MILLION VERSUS EUR 6.2 MILLION YEAR AGO
    * H1 NET RESULT SHOWS AN IMPROVEMENT OF +€0.9M TO STAND AT
€0.2M
AT THE END OF THE 1ST HALF OF 2022 AGAINST LOSS OF -€0.7M IN
2021
    * OUTLOOK: GENERATE H2 EBITDA MARGIN ABOVE H1 LEVELS
    * H1 EBITDA EUR 1.4 MILLION VERSUS EUR 0.2 MILLION YEAR AGO
    * SHAREHOLDERS' EQUITY EUR 14.8M AT 30 JUNE 2022 COMPARED TO
€14.6M AT THE END OF 2021
    * END-H1 FREE CASH FLOW WAS €6.0M, INCLUDING THE REPAYMENT
OF
€0.9M OF FINANCIAL LOANS DURING THE PERIOD

Source text for Eikon:  ID:nNDLb5ldz7 
Further company coverage:  ALGEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))

Recent news on genOway SA

See all news